Supplemental materials of Psychiatric Safety Associated with Naltrexone-Bupropion in Obesity Treatment: Insights from FDA Adverse Events Reporting System.
Published: 17 October 2024| Version 1 | DOI: 10.17632/xr7nt8k58b.1
Contributors:
Nan Chen, , Description
This dataset is the supplemental data of manuscript titled "Psychiatric Safety Associated with Naltrexone-Bupropion in Obesity Treatment: Insights from FDA Adverse Events Reporting System."
Files
Institutions
Shenzhen Second People's Hospital
Categories
Drug Adverse Reactions, Pharmacovigilance
Funding
Science, Technology and Innovation Commission of Shenzhen Municipality
JCYJ20220530150602004
Basic and Applied Basic Research Foundation of Guangdong Province
2023A1515110449